Biotronik has bagged US FDA approval for its high-voltage cardiac rhythm management (CRM) devices – Acticor and Rivacor range of devices for treating heart arrhythmia or cardiac arrhythmias. The six new tachycardia solutions approved by the FDA are Rivacor VR-T, Rivacor DR-T, Rivacor HF-T QP, Acticor DX, Acticor CRT-DX and Acticor CRT-DX Bipolar. Biotronik is […]
Biotronik, a German biomedical technology company, has received approval from the US Food and Drug Administration (FDA) for its high-voltage cardiac rhythm management (CRM) devices. These include the Acticor and Rivacor series, which are designed to treat heart arrhythmias, such as atrial fibrillation, and offer a range of innovative solutions for patients and healthcare providers […]
